2022
DOI: 10.1016/j.jpain.2021.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 58 publications
1
9
0
Order By: Relevance
“…In addition, mice treated with IgG from patients with CRPS manifested cellular changes such as microglia and astrocyte activation at the dorsal horn as well as pain regions in the brain [ 25 ]. The findings were supported by a recent study by Sahbaie and colleagues [ 26 ]. Passive transfer of serum from mice with induced fracture containing autoantibodies against the autonomic nervous system receptors and the role in pain processing were interestingly presented.…”
Section: Complex Regional Pain Syndrome (Crps)supporting
confidence: 86%
“…In addition, mice treated with IgG from patients with CRPS manifested cellular changes such as microglia and astrocyte activation at the dorsal horn as well as pain regions in the brain [ 25 ]. The findings were supported by a recent study by Sahbaie and colleagues [ 26 ]. Passive transfer of serum from mice with induced fracture containing autoantibodies against the autonomic nervous system receptors and the role in pain processing were interestingly presented.…”
Section: Complex Regional Pain Syndrome (Crps)supporting
confidence: 86%
“…The potential for trauma patients to develop chronic pain is significant, but the etiology of what predisposes a patient to the conversion from acute to chronic pain is unclear [3,56]. There are multiple contributors directly related to the trauma that increase the risk: nerve damage, tissue and muscle injury, innate immunological, and neuro-inflammatory responses [57]. However, there are additional modifiable and nonmodifiable risk factors such as: (1) phenotypic and social characteristics including age, gender, ethnicity, psychological distress, psychosocial stressors, socioeconomics, prior chronic pain, alcohol, and marijuana abuse, and illicit drug use [3] and; (2) genomic characteristics including but not limited to epigenetics, transcriptomics, proteomics, metabolomics, microbiome, and endogenous opioid systems [58][59][60][61].…”
Section: Risk Of Conversion From Acute To Chronic Painmentioning
confidence: 99%
“…Exploring this potential is very important, so it will be able to have selling power to increase the economic capacity of an area where one of the ways is to open up investment opportunities. Because investment can produce good side effects for the area on an ongoing basis (Elavarasan et al, 2021;Sahbaie et al, 2022;Widiani, 2021).…”
Section: Introductionmentioning
confidence: 99%